110 related articles for article (PubMed ID: 481845)
41. Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma.
Kidner TB; Morton DL; Lee DJ; Hoban M; Foshag LJ; Turner RR; Faries MB
J Immunother; 2012; 35(9):716-20. PubMed ID: 23090081
[TBL] [Abstract][Full Text] [Related]
42. Granulomas in melanoma patients treated with BCG immunotherapy.
Hatzitheofilou C; Obenchain DF; Porter DD; Morton DL
Cancer; 1982 Jan; 49(1):55-60. PubMed ID: 7053820
[TBL] [Abstract][Full Text] [Related]
43. Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.
Berd D; Maguire HC; McCue P; Mastrangelo MJ
J Clin Oncol; 1990 Nov; 8(11):1858-67. PubMed ID: 2230873
[TBL] [Abstract][Full Text] [Related]
44. Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.
Wood WC; Cosimi AB; Carey RW; Kaufman SD
Surgery; 1978 Jun; 83(6):677-81. PubMed ID: 644461
[TBL] [Abstract][Full Text] [Related]
45. Ultrastructural and clinical observations on skin metastases from breast cancer patients following intralesional treatment with MER/BCG vaccine.
Bar-Sella P; Bartal A; Robinson E; Nir I
Oncology; 1981; 38(4):198-203. PubMed ID: 7243173
[TBL] [Abstract][Full Text] [Related]
46. BCG immunotherapy: effects of dose and route of administration on survival of mice bearing established tumors.
Codish SD; Monaco AP
J Surg Oncol; 1978; 10(5):447-55. PubMed ID: 732331
[TBL] [Abstract][Full Text] [Related]
47. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
Winters WD; Lamm DL
Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
[TBL] [Abstract][Full Text] [Related]
48. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma.
Mastrangelo MJ; Maguire HC; Eisenlohr LC; Laughlin CE; Monken CE; McCue PA; Kovatich AJ; Lattime EC
Cancer Gene Ther; 1999; 6(5):409-22. PubMed ID: 10505851
[TBL] [Abstract][Full Text] [Related]
49. Management of recurrent melanoma of the extremity.
Shingleton WW; Seigler HF; Stocks LH; Downs RW
Cancer; 1975 Mar; 35(3):574-9. PubMed ID: 234293
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
[TBL] [Abstract][Full Text] [Related]
51. Successful transurethral intralesional BCG therapy of a bladder melanoma.
deKernion JB; Golub SH; Gupta RK; Silverstein M; Morton DL
Cancer; 1975 Nov; 36(5):1662-7. PubMed ID: 1192356
[TBL] [Abstract][Full Text] [Related]
52. Pooled analysis of the efficacy of bacille Calmette-Guerin (BCG) immunotherapy in malignant melanoma.
Tan JK; Ho VC
J Dermatol Surg Oncol; 1993 Nov; 19(11):985-90. PubMed ID: 8245304
[TBL] [Abstract][Full Text] [Related]
53. Surgical treatment of malignant melanoma.
Rosenberg SA
Cancer Treat Rep; 1976 Feb; 60(2):159-63. PubMed ID: 769968
[TBL] [Abstract][Full Text] [Related]
54. Histologic changes in the human skin melanoma after intratumorous treatment with BCG.
Svejda J; Mechl Z; Sopková B; Foukal T
Neoplasma; 1979; 26(2):215-21. PubMed ID: 471128
[TBL] [Abstract][Full Text] [Related]
55. A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.
Badalament RA; Herr HW; Wong GY; Gnecco C; Pinsky CM; Whitmore WF; Fair WR; Oettgen HF
J Clin Oncol; 1987 Mar; 5(3):441-9. PubMed ID: 3546618
[TBL] [Abstract][Full Text] [Related]
56. Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by
Yang J; Jones MS; Ramos RI; Chan AA; Lee AF; Foshag LJ; Sieling PA; Faries MB; Lee DJ
Front Oncol; 2017; 7():61. PubMed ID: 28424760
[No Abstract] [Full Text] [Related]
57. Immunological monitoring of melanoma patients on BCG immunotherapy. I. Enzyme-linked immunosorbent assay of human sera after BCG-treatment.
Kovatchev D; Kolushky V; Engibarov A
Neoplasma; 1984; 31(4):453-8. PubMed ID: 6472516
[TBL] [Abstract][Full Text] [Related]
58. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
McCulloch PB; Dent PB; Blajchman M; Muirhead WM; Price RA
Can Med Assoc J; 1977 Jul; 117(1):33-6. PubMed ID: 861909
[TBL] [Abstract][Full Text] [Related]
59. Intralesional BCG injection of pulmonary neoplasms: radiographic findings.
Fon GT; Bein ME; Holmes EC; Huberman RP
AJR Am J Roentgenol; 1981 Aug; 137(2):269-75. PubMed ID: 6789633
[TBL] [Abstract][Full Text] [Related]
60. Intratumor bacillus Calmette-Guerin therapy for chest wall recurrence of carcinoma of the breast.
Pardridge DH; Sparks FC; Goodnight JE; Wile AG; Spears IK; Morton DL
Surg Gynecol Obstet; 1979 Jun; 148(6):867-70. PubMed ID: 451808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
